References
- Ravindranath Y. Recent advances in pediatric lymphoblastic and myeloid leukemia. Curr Opin Oncol 2003;15:23–35.
- Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105–111.
- Poot M, Gibson LL, Singer L. Detection of apoptosis in live cells by Mito Tracker Red CMXRos and SYTO dye flow cytometry. Cytometry 1997;27:358–364.
- Ormerod MG. Analysis of DNA—general methods. In: Ormerod MG, editor. Flow cytometry. A practical approach. New York: Oxford University Press; 1994. p 119–135.
- Hrusak O, Porwit-MacDonald A. Antigen expression patterns reflecting genotype of acute leukemias. Leukemia 2002;16: 1233–1258.
- Oyan AM, Bo TH, Jonassen I, Ulvestad E, Gjertsen BT, Kalland K-H, Bruserud O. CD34 expression in native human acute myelogeneous leukemia blasts: Differences in CD34 membrane molecule expression are associated with different gene expression profiles. Cytometry Part B (Clinical Cyto-metry) 2005;64B:18–27.
- Langebrake C, Brinkmann I, Teigler-Schlegel A, Creutzig U, Griesinger F, Puhimam U, Reinhardt D. Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoring. Cytometry Part B (Clinical Cytometry) 2005;63B:1–9.
- Borowitz MJ, Pullen DJ, Winick N, Martin PL, Bowman WP, Camitta B. Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: Implications for residual disease detection: A report from the children's oncology group. Cytometry part B (Clinical Cytometry) 2005;68B:18–24.
- Meleshko A, Savitski V, Shman T, Aleinikova O. Immuno-phenotypically heterogeneous acute T-lymphoblastic leukemia has invariable immunogenotype: Analysis of two cases. J Pediatr Hematol Oncol 2006;28:50–52.
- Holleman A, Den Boer M, Kazemier KNI, Janka-Schaub GE, Pieters R. Resistance to different classes of drugs is associated with impaired apoptosis in childhood ALL. Blood 2003;102: 4536–4541.
- van Stijn A, van der Pol MA, Kok A, Bontje PM, Roemen GMJM, Beelen RFIJ, Ossenkoppele GJ, Schuurhuis GJ. Differences between the CD34+ and CD34— blast compart-ment in apoptosis resistance in acute myeloid leukemia. Haematologica 2004;88:497–508.
- Stanke K, Eckhoff S, Mohr A, Meyer LH, Debatin K-M. Apoptosis induction in peripheral leukemia cells by remission induction treatment in vivo: Selective depletion and apoptosis in a CD34+ subpopulation of leukemia cells. Leukemia 2003; 17:2130–2139.
- Holtz MS, Forman SJ, Bhatia R. Nonproliferating CML CD34+ progenitors are resistant to apoptosis induced by a wide range of proapoptotic stimuli. Leukemia 2005;19: 1034–1041.
- Preisler HD, Raza A, Bonomi P, Taylor S, LaFolette S, Leslie W, Lincoln S. Regrowth resistance as a likely significant contributor to treatment failure in drug-sensitive neoplastic diseases. Cancer Invest 1997;15:358–368.